Device manufacturer, as written on reports
Medtronic Neuromodulation: medical device reports filed with FDA
59,218 reports name it as the manufacturer of the device involved, 2005–2026.
- 59,218
- reports naming it as manufacturer
- 0.2% of all MAUDE reports
- 3,385
- reports, 12 months to August 2026
- 3,326 in the 12 months before
- 43.6%
- classified as malfunction
- 62.3% across all reports
- 1.3%
- classified as death, as reported
- 0.9% across all reports
59,218 medical device reports received by FDA give Medtronic Neuromodulation as the manufacturer of the device involved, 0.2% of the MAUDE database, from September 2005 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
3,385 reports arrived in the 12 months to August 2026, close to the 3,326 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (54.9%), malfunction (43.6%) and death (1.3%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Implantable Neurostimulator | Stimulator, spinal-cord, totally implanted for pain relief | 6,133 | 692 | 0.3% |
| Unknown Implantable Neurostimulator | Stimulator, spinal-cord, totally implanted for pain relief | 3,801 | 0 | 2.2% |
| Verify Enhanced | Stimulator, electrical, implantable, for incontinence | 3,635 | 295 | 0% |
| Interstim | Stimulator, electrical, implantable, for incontinence | 3,043 | 1,522 | 0.2% |
| Activa | Stimulator, electrical, implanted, for parkinsonian tremor | 2,635 | 1,112 | 0.6% |
| Verify | Stimulator, electrical, implantable, for incontinence | 2,276 | 8 | 0% |
| Intellis | Stimulator, spinal-cord, totally implanted for pain relief | 2,027 | 4,743 | 0% |
| Synchromed | Pump, infusion, implanted, programmable | 1,385 | 3 | 3.2% |
| External Neurostimulator | Stimulator, spinal-cord, totally implanted for pain relief | 1,168 | 102 | 0.4% |
| Unknown External Neurostimulator | Stimulator, electrical, implantable, for incontinence | 718 | 0 | 1.1% |
| Implantable Drug Infusion Pump | Pump, infusion, implanted, programmable | 582 | 177 | 0.9% |
| Unknown Deep Brain Stimulator | Stimulator, electrical, implanted, for parkinsonian tremor | 556 | 0 | 4.9% |
| Enterra | Intestinal stimulator | 533 | 0 | 0.8% |
| Deep Brain Stimulation Lead | Stimulator, electrical, implanted, for parkinsonian tremor | 527 | 0 | 3.8% |
| Kinetra | Stimulator, electrical, implanted, for parkinsonian tremor | 526 | 1 | 2.1% |
| SureScan | Stimulator, spinal-cord, totally implanted for pain relief | 515 | 490 | 0% |
| Unknown Spinal Cord Stimulator | Stimulator, spinal-cord, totally implanted for pain relief | 466 | 0 | 1.2% |
| Unknown Neurostimulator | Stimulator, spinal-cord, totally implanted for pain relief | 462 | 0 | 1.7% |
| Ascenda | Pump, infusion, implanted, programmable | 439 | 14 | 0.9% |
| Restore | Stimulator, spinal-cord, totally implanted for pain relief | 413 | 27 | 0.1% |
| Indura | Pump, infusion, implanted, programmable | 381 | 0 | 0.8% |
| Infusion Pump | Pump, infusion, implanted, programmable | 368 | 6 | 3.7% |
| Soletra | Stimulator, electrical, implanted, for parkinsonian tremor | 356 | 12 | 4.2% |
| Percept | Stimulator, electrical, implanted, for parkinsonian tremor | 352 | 1,239 | 0.3% |
| Neu Ins Stimulator | Stimulator, spinal-cord, totally implanted for pain relief | 305 | 0 | 2.1% |
| Itrel 3 | Stimulator, spinal-cord, totally implanted for pain relief | 287 | 10 | 1.4% |
| InterStim X | Stimulator, electrical, implantable, for incontinence | 273 | 3,163 | 0% |
| Synchromed El | Pump, infusion, implanted, programmable | 256 | 2 | 4.9% |
| Restore Ultra | Stimulator, spinal-cord, totally implanted for pain relief | 225 | 39 | 0.1% |
| Unknown Implantable Pump | Pump, infusion, implanted, programmable | 222 | 0 | 2.6% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| LKK | Pump, infusion, implanted, programmable | 16,987 | 28.7% |
| EZW | Stimulator, electrical, implantable, for incontinence | 13,918 | 23.5% |
| LGW | Stimulator, spinal-cord, totally implanted for pain relief | 13,746 | 23.2% |
| MHY | Stimulator, electrical, implanted, for parkinsonian tremor | 11,496 | 19.4% |
| LNQ | Intestinal stimulator | 787 | 1.3% |
| MRU | Implanted subcortical electrical stimulator (motor disorders) | 633 | 1.1% |
| DTB | Permanent pacemaker electrode | 237 | 0.4% |
| GZB | Stimulator, spinal-cord, implanted (pain relief) | 123 | 0.2% |
| LWS | Implantable cardioverter defibrillator (non-crt) | 100 | 0.2% |
| PJS | Stimulator, electrical, implanted, for essential tremor | 94 | 0.2% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Medtronic Neuromodulation reports
How many FDA device reports name Medtronic Neuromodulation as manufacturer?
59,218 reports through August 2026, 3,385 of them in the latest 12 months.
Which of its brands appear most often?
Implantable Neurostimulator (6,133), Unknown Implantable Neurostimulator (3,801), Verify Enhanced (3,635), Interstim (3,043) and Activa (2,635).
Which device types does it report on?
pump, infusion, implanted, programmable (28.7%), stimulator, electrical, implantable, for incontinence (23.5%), stimulator, spinal-cord, totally implanted for pain relief (23.2%) and stimulator, electrical, implanted, for parkinsonian tremor (19.4%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.